申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20220388987A1
公开(公告)日:2022-12-08
There are disclosed compounds of the following formula I:
or a stereoisomer or pharmaceutically acceptable salt thereof, wherein all substituents are as defined herein, which are useful in the modulation of IL-12, IL-23 and/or IFNα, by acting on Tyk-2 to cause signal transduction inhibition. The compounds of the invention may be useful for treating neurodegenerative diseases or disorders.
公开了以下化合物的化学式I或其立体异构体或药学上可接受的盐,其中所有取代基的定义如本文所述,这些化合物通过作用于Tyk-2以引起信号转导抑制,对调节IL-12、IL-23和/或IFNα具有用处。本发明的化合物可能有助于治疗神经退行性疾病或障碍。